- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07942207
Spanish Registry of Cardioneuroablation (SRCNA)
Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.
Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.
Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.
Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.
Study population
Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:
- Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
- Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
- Functional sinus node dysfunction.
- Functional AV block. Procedure
CNA is performed according to the usual practice of each center. The operator chooses:
- the approach (right atrium, left atrium or both);
- the number of GP targeted;
- the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
- the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
- Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
- Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
- Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
- Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.
Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.
Ongoing sub-studies:
- long-term follow-up of these patients and identification of predictors of recurrence;
- redo procedures, in patients requiring more than one CNA;
- patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Maria T Barrio-Lopez, MD PhD
- Telefonnummer: +34 655298270
- E-post: terebarriol@gmail.com
Studer Kontakt Backup
- Navn: Jesus Almendral
- E-post: almendraljesus@gmail.com
Studiesteder
-
-
-
Albacete, Spania
- Rekruttering
- Hospital Albacete
-
Alicante, Spania
- Rekruttering
- Hospital General Alicante
-
Ta kontakt med:
- Jose Luis Ibañez
- E-post: ppluic77@gmail.com
-
Badajoz, Spania
- Rekruttering
- Hospital Badajoz
-
Barcelona, Spania
- Rekruttering
- Hospital Dexeus Barcelona
-
Ta kontakt med:
- Ángel Moya
- E-post: amoyamitjans@gmail.com
-
Barcelona, Spania
- Rekruttering
- Hospital Vall d´Hebron
-
Bilbao, Spania
- Rekruttering
- Hospital de Basurto
-
Ta kontakt med:
- Jesus Martinez
- E-post: txules@gmail.com
-
Córdoba, Spania
- Rekruttering
- Hospital Reina Sofia
-
Girona, Spania
- Rekruttering
- Hospital Josep Trueta
-
Granada, Spania
- Rekruttering
- Hospital Virgen de las Nieves
-
Granada, Spania
- Rekruttering
- Hospital Clinico Granada
-
Ta kontakt med:
- Rosa Macias
- E-post: rmacias148@msn.com
-
Huelva, Spania
- Rekruttering
- Hospital Juan Ramón Jiménez
-
Madrid, Spania
- Rekruttering
- Hospital Puerta de Hierro
-
Ta kontakt med:
- Eusebio Garcia Izquierdo
- E-post: usegij@gmail.com
-
Madrid, Spania
- Rekruttering
- Hospital 12 de Octubre
-
Ta kontakt med:
- Alvaro Marco, amarco89@hotmail.com
-
Madrid, Spania
- Rekruttering
- Hospital Fundación Jiménez Díaz
-
Madrid, Spania
- Rekruttering
- Hospital Gregorio Marañon
-
Madrid, Spania
- Rekruttering
- Hospital Ramón y Cajal
-
Ta kontakt med:
- Eduardo Franco
- E-post: efranco@academiamir.com
-
Madrid, Spania
- Rekruttering
- Hospital Torrejon
-
Ta kontakt med:
- Teba González
- E-post: tebagf@gmail.com
-
Navarro, Spania
- Rekruttering
- Hospital Universitario de Navarra
-
Ta kontakt med:
- Oscar Alcalde
- E-post: 37053oar@gmail.com
-
Santander, Spania
- Rekruttering
- Hospital Valdecilla
-
Santiago de Compostela, Spania
- Rekruttering
- Hospital Santiago de Compostela
-
Ta kontakt med:
- Carlos Minguito
- E-post: carlosminguito@hotmail.es
-
Valencia, Spania
- Rekruttering
- Hospital La Fe
-
Valladolid, Spania
- Rekruttering
- Hospital Valladolid
-
Vigo, Spania
- Rekruttering
- Hospital Álvaro Cunqueiro
-
Vitoria-Gasteiz, Spania
- Rekruttering
- Hospital Txagorritxu
-
Zaragoza, Spania
- Rekruttering
- Hospital Miguel Servet
-
-
Madrid
-
Madrid, Madrid, Spania, 28660
- Rekruttering
- Hospital HM Monteprincipe
-
Ta kontakt med:
- Teresa Barrio, MD PhD
- Telefonnummer: 655298270
- E-post: terebarriol@gmail.com
-
Madrid, Madrid, Spania
- Rekruttering
- Hospital La Paz
-
Ta kontakt med:
- Carlos Alvarez
- E-post: calvarezo@gmail.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
patients treated with cardioneuroablation
Beskrivelse
Inclusion Criteria:
- patients treated with cardioneuroablation
Exclusion Criteria:
-
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
syncope
Tidsramme: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
recurrence of syncope |
From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Complications
Tidsramme: During procedure and 3 months after
|
Complications |
During procedure and 3 months after
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- SEC2021
- Spanish Society of Cardiology (Annet stipend/finansieringsnummer: Cardiac Rhythm society)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .